SUMO-mediated regulation of NLRP3 modulates inflammasome activity

被引：167

作者：

Barry, Rachael ^{[1
,2
]}

John, Sidonie Wicky ^{[1
]}

Liccardi, Gianmaria ^{[1
]}

Tenev, Tencho ^{[1
]}

Jaco, Isabel ^{[1
]}

Chen, Chih-Hong ^{[3
]}

Choi, Justin ^{[3
]}

Kasperkiewicz, Paulina ^{[4
]}

Fernandes-Alnemri, Teresa ^{[5
]}

Alnemri, Emad ^{[5
]}

Drag, Marcin ^{[4
]}

Chen, Yuan ^{[3
]}

Meier, Pascal ^{[1
]}

机构：

[1] Breast Canc Now Toby Robins Res Ctr, Inst Canc Res, Chester Beatty Labs, Mary Jean Mitchell Green Bldg,237 Fulham Rd, London SW3 6JB, England

[2] Imperial Coll London, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England

[3] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA

[4] Wroclaw Univ Technol, Dept Chem, Div Bioorgan Chem, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland

[5] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA

来源：

NATURE COMMUNICATIONS | 2018年 / 9卷

基金：

英国生物技术与生命科学研究理事会;

关键词：

NF-KAPPA-B; PROTEIN MODIFICATION; SUMOYLATION SITES; IN-SITU; ACTIVATION; CRYOPYRIN; DISEASE; HEALTH; DEUBIQUITINATION; PHOSPHORYLATION;

D O I：

10.1038/s41467-018-05321-2

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The NLRP3 inflammasome responds to infection and tissue damage, and rapidly escalates the intensity of inflammation by activating interleukin (IL)-1 beta, IL-18 and cell death by pyroptosis. How the NLRP3 inflammasome is negatively regulated is poorly understood. Here we show that NLRP3 inflammasome activation is suppressed by sumoylation. NLRP3 is sumoylated by the SUMO E3-ligase MAPL, and stimulation-dependent NLRP3 desumoylation by the SUMO-specific proteases SENP6 and SENP7 promotes NLRP3 activation. Defective NLRP3 sumoylation, either by NLRP3 mutation of SUMO acceptor lysines or depletion of MAPL, results in enhanced caspase-1 activation and IL-1 beta release. Conversely, depletion of SENP7 suppresses NLRP3-dependent ASC oligomerisation, caspase-1 activation and IL-1 beta release. These data indicate that sumoylation of NLRP3 restrains inflammasome activation, and identify SUMO proteases as potential drug targets for the treatment of inflammatory diseases.

引用

页数：14

共 61 条

[1] Heterologous SUMO-2/3-Ubiquitin Chains Optimize IκBα Degradation and NF-κB Activity
Aillet, Fabienne
Lopitz-Otsoa, Fernando
Egana, Isabel
Hjerpe, Roland
Fraser, Paul
Hay, Ron T.
Rodriguez, Manuel S.
Lang, Valerie
[J]. PLOS ONE, 2012, 7 (12):
[2] Genetics of monogenic autoinflammatory diseases: past successes, future challenges
Aksentijevich, Ivona
Kastner, Daniel L.
[J]. NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (08) : 468 - 477
[3] Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Bauernfeind, Franz G.
Horvath, Gabor
Stutz, Andrea
Alnemri, Emad S.
MacDonald, Kelly
Speert, David
Fernandes-Alnemri, Teresa
Wu, Jianghong
Monks, Brian G.
Fitzgerald, Katherine A.
Hornung, Veit
Latz, Eicke
[J]. JOURNAL OF IMMUNOLOGY, 2009, 183 (02) : 787 - 791
[4] JASSA: a comprehensive tool for prediction of SUMOylation sites and SIMs
Beauclair, Guillaume
Bridier-Nahmias, Antoine
Zagury, Jean-Francois
Saib, Ali
Zamborlini, Alessia
[J]. BIOINFORMATICS, 2015, 31 (21) : 3483 - 3491
[5] Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1
Bernier-Villamor, V
Sampson, DA
Matunis, MJ
Lima, CD
[J]. CELL, 2002, 108 (03) : 345 - 356
[6] MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission
Braschi, Emelie
Zunino, Rodolfo
McBride, Heidi M.
[J]. EMBO REPORTS, 2009, 10 (07) : 748 - 754
[7] Clinical and genetic characterization of Italian patients affected by CINCA syndrome
Caroli, F.
Pontillo, A.
D'Osualdo, A.
Travan, L.
Ceccherini, I.
Crovella, S.
Alessio, M.
Stabile, A.
Gattorno, M.
Tommasini, A.
Martini, A.
Lepore, L.
[J]. RHEUMATOLOGY, 2007, 46 (03) : 473 - 478
[8] A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, Rebecca C.
Robertson, Avril A. B.
Chae, Jae Jin
Higgins, Sarah C.
Munoz-Planillo, Raul
Inserra, Marco C.
Vetter, Irina
Dungan, Lara S.
Monks, Brian G.
Stutz, Andrea
Croker, Daniel E.
Butler, Mark S.
Haneklaus, Moritz
Sutton, Caroline E.
Nunez, Gabriel
Latz, Eicke
Kastner, Daniel L.
Mills, Kingston H. G.
Masters, Seth L.
Schroder, Kate
Cooper, Matthew A.
O'Neill, Luke A. J.
[J]. NATURE MEDICINE, 2015, 21 (03) : 248 - +
[9] The inflammasomes in health and disease: from genetics to molecular mechanisms of autoinflammation and beyond
Conforti-Andreoni, Cristina
Ricciardi-Castagnoli, Paola
Mortellaro, Alessandra
[J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2011, 8 (02) : 135 - 145
[10] SUMO-1 modification of IκBα inhibits NF-κB activation
Desterro, JMP
Rodriguez, MS
Hay, RT
[J]. MOLECULAR CELL, 1998, 2 (02) : 233 - 239

← 1 2 3 4 5 6 7 →